title: Quetiapine lowers sympathetic and hyperthermic reactions due to cerebral injection of orexin A.
abstract: Since no experiment regarding a possible relation between quetiapine and orexin A has been reported in international literature, this experiment tested the effect of quetiapine on the sympathetic and thermogenic effects induced by orexin A. The firing rates of the sympathetic nerves to interscapular brown adipose tissue (IBAT), along with IBAT, colonic temperatures and heart rate were monitored in urethane-anesthetized male Sprague-Dawley rats before an injection of orexin A (1.5 nmol) into the lateral cerebral ventricle and over a period of 150 min after the injection. The same variables were monitored in rats with an intraperitoneal administration of quetiapine (5 or 10 mg/kg bw), injected 30 min before the orexin administration. The results show that orexin A increases the sympathetic firing rate, IBAT, colonic temperatures and heart rate. This increase is delayed or reduced by the injection of quetiapine. These findings indicate that quetiapine affects the complex reactions related to activation of orexinergic system. Possible influences on the control of body weight and temperature are discussed.
authors.affiliation: Department of Experimental Medicine, Section of Human Physiology, Second University of Naples, Via Costantinopoli 16, 80138 Naples, Italy. marcellino.monda@unina2.it
authors.forename: M
authors.initials: M
authors.lastname: Monda
authors.forename: An
authors.initials: A
authors.lastname: Viggiano
authors.forename: Al
authors.initials: A
authors.lastname: Viggiano
authors.forename: E
authors.initials: E
authors.lastname: Viggiano
authors.forename: G
authors.initials: G
authors.lastname: Messina
authors.forename: D
authors.initials: D
authors.lastname: Tafuri
authors.forename: V
authors.initials: V
authors.lastname: De Luca
mesh_terms: D002001:Adipose Tissue, Brown / Q000187:drug effects / Q000502:physiology; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001835:Body Weight / Q000187:drug effects; D003987:Dibenzothiazepines / Q000494:pharmacology*; D004567:Electrodes, Implanted; D005334:Fever / Q000503:physiopathology*; D006339:Heart Rate / Q000187:drug effects; D007276:Injections, Intraventricular; D047908:Intracellular Signaling Peptides and Proteins / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D009479:Neuropeptides / Q000008:administration & dosage / Q000494:pharmacology*; D000068797:Orexins; D000069348:Quetiapine Fumarate; D051381:Rats; D017207:Rats, Sprague-Dawley; D013564:Sympathetic Nervous System / Q000187:drug effects*
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; C000596229:HCRT protein, human; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins; D000069348:Quetiapine Fumarate